BioRestorative Therapies, Inc. stock is down -0.52% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30.43% of the previous 26 December’s closed higher than November.
The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies in August 2011.